A comparison of a CB17 scid mouse model and the tetrazolium-dye assay using human haematological tumour cell lines

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 6, 1996, Pages 548-552

  Cattan, A R ^a   Maung, Z T ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Drug resistance; Leukaemia; MTT; Myeloma; Scid mice

Indexed keywords

4 HYDROPEROXYIFOSFAMIDE; ANTINEOPLASTIC AGENT; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE;

ANIMAL MODEL; ARTICLE; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESISTANCE; DRUG SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOBLASTOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAJI CELL; SCID MOUSE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BURKITT LYMPHOMA; COLORING AGENTS; DAUNORUBICIN; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ETOPOSIDE; FEMALE; HUMANS; IDARUBICIN; LEUKEMIA, EXPERIMENTAL; MALE; MICE; MICE, SCID; MULTIPLE MYELOMA; TETRAZOLIUM SALTS; TOXICITY TESTS; TUMOR CELLS, CULTURED;

EID: 0029799715     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050525     Document Type: Article

References (28)

1. Mosmann TJ (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxictty assays. J Immunol Methods 65:55
2. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumour cell lines using a microculture tetrazolium assay. Cancer Res 48:589
3. Parker AN, Hutchinson RM, Chapman CS, Bosanquet AG (1992) Effective treatment of relapsed acute myeloid leukaemia with drugs chosen by DiSC assay. Br J Haematol 81:455
4. Henze G, Agthe AG, Neuendank A, Harmann R, Dörffel WE, Brühmüller S, Klumper E, Pieters R, Veerman AJP (1995) Tailored therapy for relapsed or refractory childhood acute lymphoblastic leukemia (abstract). Leukemia 9:538
5. Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301:527
6. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645
7. Goan S-R, Fichtner I, Just U, Karawajew L, Schultze W, Krause K-P, Von Harsdorf S, Von Schilling C, Herrmann F (1995) The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis. Blood 86:89
8. Heike Y, Ohira T, Takahushi M, Saijo N (1995) Long-term human hematopoiesis in SCID-hu mice bearing transplanted fragments of adult bone and bone marrow cells. Blood 86:524
9. Duchosal MA, Eming SA, Fischer P, Leturcq D, Barbas CF III, McConahey PJ, Caothien RH, Thornton GB, Dixon FJ, Burton DR (1992) Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries. Nature 355:258
10. Mosier DE, Gulizia RJ, Baird SM, Wilson DB (1988) Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256
11. Krams SM, Dorshkind K, Gershwin ME (1989) Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J Exp Med 170:1919
12. Davies TF, Kimura H, Fong P, Kendler D, Shultz LD, Thung S, Martin A (1991) The SCID-hu mouse and thyroid autoimmunity: characterization of human thyroid autoantibody secretion, Clin Immunol Immunopathol 60:319
13. Heike Y, Takahashi M, Ohira T, Arioka H, Funayama Y, Nishio K, Ogasawara H, Saijo N (1995) In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice. Cancer Chemother Pharmacol 35:200
14. Cattan AR, Douglas E (1994) The C.B.17 scid mouse strain as a model for human disseminated leukaemia and myeloma in vivo. Leuk Res 18:513
15. Maung ZT, Reid MM, Matheson E, Taylor PRA, Proctor SJ, Hall AG (1995) Corticosteroid resistance is increased in lymphoblasts from adults compared with children. Preliminary results of an in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia. Br J Haematol 91:93
16. Maung ZT, Hall AG, Reid MM, Proctor SJ (1993) In vitro drug sensitivity in acute lymphoblastic leukaemia using the tetrazolium-based MTT assay (abstract). Br J Haematol 84 [Suppl 1]: 29
17. Gouyelle A, Hartmann O, Pico J-L (1986) Pharmacokinetics of high-dose melphalan in children and adults. Cancer Chemother Pharmacol 16:184
18. Foa R, Guarini A, Gillio Tos A, Cardona S, Fierro MT, Meloni G, Tosti S, Mandelli F, Gavosto F (1991) Peripheral blood and bone marrow immunophenotypic and funcional modifications induced in acute leukemia patienls treated with interleukin 2: evidence of in vivo lymphokine activated killer cell generation. Cancer Res 51:964
19. Gottlieb DJ, Prentice HG, Heslop HE, Bello-Fernandez C, Bianchi AG, Galazka AR, Brenner MK (1989) Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for heamotological malignancy. Blood 74:2335
20. Reddy S, Piccione D, Takita H, Bankert RB (1987) Human lung tumor growth established in the lung and subcutaneous tissue of mice with severe combined immunodeficiency. Cancer Res 47:2456
21. Kamel-Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulup G, Freedman MH, Phillips RA, Dick JE (1989) A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 246:1597
22. Charley MR, Tharp M, Locker J, Deng J-S, Goslen JB, Mauro T, McCoy P, Abell E, Jegasothy B (1990) Establishment of a human cutaneous T-cell lymphoma in C.B-17 SCID mice. J Invest Dermatol 94:381
23. Al-Katib A, Mohammad R, Muhammad H, Mohamed AN, Dan M, Smith MR (1993) Propagation of Waldenstrom's macroglobulinemia cells in vitro and in severe combined immune deficient mice: utility as a preclinical drue screening model. Blood 81:3034
24. Ucken FM, Chelstrom LM, Finnegan D, Tucl-Ahlgren L, Manivel C, Irvin JD, Myers DE, Gunther R (1992) Effective immunochemotherapy of CALLA+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide. Blood 79:3116
25. Jansen B, Uckun FM, Jaszcz WB, Kersey JH (1992) Establishment of a human t(4;11) leukemia in severe combined immunodeficient mice and successful treatment using anti-CD19 (B43)-pokeweed antiviral protein immunotoxin. Cancer Res 52:406
26. Uckun FM, Chelstrom LM, Irvin JD, Finnegan D, Gunther R, Young J, Kuebelbeck V, Myers DE, Houston LL (1992) In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia. Blood 79:2649
27. Jansen B, Vallera DA, Jaszcz WB, Nguyen D, Kersey JH (1992) Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7. Cancer Res 52:1314
28. Ninane J, Baurain R, Kraker de J, Ferster A, Trouet A, Corru G (1989) Alkylating activity in serum, urine and CSF folllowing high-dose ifosfamide in children. Cancer Chemother Pharmacol 24:S2